Oncology AACR 2025: New modalities and remaining challenges Explore the latest advancements and challenges in ADC therapy at AACR 2025: New modalities and remaining challenges
Oncology Beyond COVID-19: mRNA vaccines aim to revolutionise cancer c... mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment.
News BMS suffers further setback in lung cancer No fast approval for immunotherapy combo in first line use.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
